Prevention of venous thrombosis in cancer patients: A prospective, randomized, double-blind study comparing two different dosages of low-molecular weight heparin

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-002068-27

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

to investigate the effect of LMWH on hemostatic system activation, as measured by the levels of F1+2 and D-dimer, in cancer patients to compare the effects of two different dosages of enoxaparin (40 mg od sc and 80 mg od sc) on these markers of hemostatic system activation in cancer patients


Critère d'inclusion

  • cancer patients

Liens